RCEL

AVITA Medical Inc.

Price

$10.31

return (12m)

135.39%

p/e

-7.13

p/bv

-11.03

DIVIDEND YIELD

0.00%

RCEL price

AVITA Medical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RCEL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

127.34%

3 months

138.11%

1 year

135.39%

2 years

13.17%

5 years

-48.78%

10 years

68.97%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals RCEL

Valuation

P/E

-7.13

Sector -4.26

Industry -4.26

P/BV

-11.03

Sector 2.11

Industry 2.11

P/Revenue (PSR)

4.06

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

6.43

Sector 1.25

Industry 1.25

P/Net Current Assets

-6.51

Sector -5.47

Industry -5.47

P/Working Capital

-7.62

Sector -1.10

Industry -1.10

EPS

-1.39

Sector -1.94

Industry -1.94

BVPS

-0.90

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

81.57%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-46.57%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-56.96%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.45

Sector 0.03

Industry 0.03

Profitability

ROE

154.74%

Sector -61.50%

Industry -61.50%

ROA

-90.16%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.41

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

-0.58

Sector 0.43

Industry 0.43

Liabilities/Assets

1.58

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

23.72%

Sector -

Industry -

5Y Earnings CAGR

20.91%

Sector -

Industry -

Fundamentals RCEL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RCEL AVITA Medical Inc.	$10.31	127.59%	0.00%	-7.13	-11.03	154.74%	-56.96%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RCEL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT AVITA Medical

AVITA Medical Inc.

Average Investor10 user rating

4.0 (0 people)

United States

34 years

Founded: 1992

Time since IPO - - year

108

Employees

AVITA Medical Inc. (United States) is listed on the Nasdaq and has a market capitalization of $307.21 million, with shareholders equity totaling $-27.84 million.

The company employs approximately 108 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, AVITA Medical Inc. reported $75.63 million in revenue, generating net income of $-43.08 million.

Key financial metrics include a P/E ratio of -7.13, a price-to-book (P/B) ratio of -11.03, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RCEL.

Market cap

$307.21 million

Net worth

$-27.84 million

$-27,840,000.00

Assets

$47.78 million

$47,780,000.00

Total Shares Outstanding

31.00 million

31,000,000

Average Daily Trading Volume

Sector

Health Care

Industry

Biotechnology

RCEL

RCEL revenue and profits

Financial Results RCEL

DRAG THE FRAME TO SEE MORE DATA

RCEL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of AVITA Medical (RCEL) today?

A cotação de AVITA Medical (RCEL) hoje está em US$ 10.31, com uma variação de 135.39% em relação ao último ano. A cotação de AVITA Medical (RCEL) iniciou o ano negociando na casa dos US$ 3.45 e hoje está em US$ 10.31. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de AVITA Medical (RCEL) e dados de ações do Ibovespa e mercados internacionais.

Quando AVITA Medical (RCEL) paga dividendos?

AVITA Medical (RCEL) não distribuiu dividendos no último ano.

Is AVITA Medical (RCEL) a good investment?

Atualmente, AVITA Medical (RCEL) está cotada a US$ 10.31, com um P/L de -7.13, representando um desvio de -614% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 135.39 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 135.39%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy AVITA Medical (RCEL) stock?

Investir em ações de AVITA Medical (RCEL) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of AVITA Medical (RCEL) yield today?

A rentabilidade de AVITA Medical (RCEL) foi de 127.34% no último mês, 135.39% no último ano e -48.78% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de AVITA Medical (RCEL) hoje, o investimento total seria de US$ 1,031.00, com base na cotação atual de US$ 10.31.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,426.87
Em 5 anos: US$ 528.08
Em 10 anos: US$ 1,742.08

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RCEL

AVITA Medical Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RCEL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING RCEL WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT AVITA Medical

AVITA Medical Inc.

United States

34 years

108

PROFIT X PRICE RCEL

Financial Results RCEL

RCEL cash flow

Asset, Revenue and Profit Growth - RCEL

RCEL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions